The Inflammatory Engine of Ageing Hearts
A comprehensive review in the European Heart Journal details the complex interplay between systemic ageing and heart failure, with a specific focus on immunosenescence and chronic low-grade inflammation, termed “inflammaging.” The analysis highlights how ageing-related immune dysfunction—including impaired autophagy, mitochondrial stress, and cellular senescence—compromises cardiac energy homeostasis and promotes myocardial cell loss. Notably, the review points out that while these immune and inflammatory pathways are central to disease progression in the elderly, they are not directly targeted by current guideline-recommended heart failure therapies, presenting a significant translational gap.
Why it might matter to you: This work directly connects fundamental immunology concepts like inflammaging and immunosenescence to a major clinical endpoint, heart failure. For an immunologist, it underscores the critical role of innate immunity and cytokine networks in a prevalent age-related disease where immune mechanisms are recognized but not yet therapeutically harnessed. It identifies a clear avenue for research into novel immunomodulatory strategies or adjuvants that could complement existing treatments, moving beyond the adaptive immune focus of many current immunotherapies.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.
